What is Lmnx stock?
Luminex. Luminex Corporation, is a technologies and applications company. The Company develops, manufactures and sell biological testing technologies and products with applications in the life sciences and diagnostics industries.
Should I buy Luminex stock?
Is Luminex a buy right now? 2 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Luminex in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should “hold” Luminex stock.
What happened Luminex stock?
Transaction Details in Brief Per the deal, Luminex will get merged with DiaSorin’s newly formed U.S. subsidiary, with the former’s shareholders receiving $37 in cash for each of their shares. It is worth mentioning that the transaction will be funded through a mix of cash and external financing.
How much is Luminex worth?
$1.75 Billion
Market cap: $1.75 Billion As of April 2022 Luminex has a market cap of $1.75 Billion. This makes Luminex the world’s 3626th most valuable company by market cap according to our data.
What is Luminex technology?
Luminex Overview Luminex xMap technology is a bead-based multiplexed immunoassay system in a microplate format. The system can simultaneously detect many targets in a single sample — up to 500, depending on system design. The microspheres used in the Luminex system have different spectral addresses (color codes).
Who purchased Luminex?
DiaSorin
NEW YORK ─ DiaSorin said on Sunday that it has signed an agreement to acquire Luminex for approximately $1.8 billion in cash. Under the terms of the agreement, Luminex’s shareholders will receive $37 for each share of their stock in the Austin, Texas-based company.
What does Luminex company do?
Luminex Corporation | A DiaSorin Company is a biotechnology company which develops, manufactures and markets proprietary biological testing technologies with applications in life-sciences.
Is Luminex an ELISA?
Key differences between ELISA and LUMINEX assays are the use of different target capture systems and different reporter systems. LUMINEX assays capture targets onto spherical beads in suspension while ELISAs generally rely on flat surfaces in multi-well plates to capture targets.
How does Luminex 200 work?
Phycoerythrin (PE)-conjugated streptavidin is added. It binds to the biotinylated detection antibodies. Beads are read on a dual-laser flow-based detection instrument, such as the Luminex 200™ or FlexMap® analyzer. One laser classifies the bead and determines the analyte that is being detected.
Is Luminex a good company to work for?
Is Luminex a good company to work for? Luminex has an overall rating of 3.5 out of 5, based on over 243 reviews left anonymously by employees. 60% of employees would recommend working at Luminex to a friend and 50% have a positive outlook for the business. This rating has decreased by -4% over the last 12 months.
Is Luminex a public company?
Luminex Corporation | A DiaSorin Company is a biotechnology company which develops, manufactures and markets proprietary biological testing technologies with applications in life-sciences….Luminex Corporation.
| Type | Subsidiary |
|---|---|
| Industry | Biotechnology |
| Founded | 1995 |
| Headquarters | Austin, Texas, United States, |
Is Luminex more sensitive than ELISA?
The ELISA accuracy is 96.5%. Thus, the two assays are comparable for specificity and accuracy, and the Luminex assay is more sensitive than the ELISA.
What is Luminex’s (lmnx) stock price?
What is Luminex’s stock symbol? Luminex trades on the NASDAQ under the ticker symbol “LMNX.” What is Luminex’s stock price today? One share of LMNX stock can currently be purchased for approximately $36.99. How much money does Luminex make? Luminex has a market capitalization of $1.75 billion and generates $417.40 million in revenue each year.
Are Luminex insiders buying or selling stock?
In the past three months, Luminex insiders have not sold or bought any company stock. Only 6.60% of the stock of Luminex is held by insiders. 87.76% of the stock of Luminex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
What is Google Finance?
Google Finance provides real-time market quotes, international exchanges, up-to-date financial news, and analytics to help you make more informed trading and investment decisions.
What is Luminex’s return on equity?
Luminex had a net margin of 5.39% and a trailing twelve-month return on equity of 4.66%. Luminex’s quarterly revenue was up 23.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.07 EPS. View Luminex’s earnings history. How often does Luminex pay dividends?